NCT05314478

Brief Summary

Exercise-induced laryngeal obstruction (EILO) is a condition in which the larynx, or voice box, narrows during high-intensity exercise, and is often mis-diagnosed. A test called a Continuous Laryngoscopy during Exercise (CLE) test can be performed, where a flexible camera is inserted through the nose and positioned at the back of the throat. While the patient exercises, the camera image can be used to identify the presence of EILO. During the CLE test it is important that the part of the camera that remains outside the body is held securely in position near the forehead so that a clear and stable image is obtained using a headgear to secure the camera to the patient's head. There are no headgears available on the market, so we have designed and manufactured one called HALOS (Headgear Accessory for Exercise-Induced Laryngeal Obstruction Studies). This study is to ensure that HALOS is suitable for use, and to check we have understood and minimised the risks associated with the headgear. The headgear can then be used routinely within the Trust, improving the care that offered to patients. We will recruit 30 male or female participants who need to undergo a CLE test. The study will be conducted at Broadgreen Hospital, Liverpool, UK. Before the CLE test, participants will attend a screening appointment to discuss the procedure. There will be no follow-up appointments. During the CLE test, the participants will wear the HALOS headgear while exercising, and the clinician will monitor the image from the camera for signs of EILO. After the test, participants will be asked how tolerable the headgear was, and if they have any concerns about any aspect of it. The clinician will also record how clear and stable the camera image was, how easy it was to use, and any concerns about any aspect of it.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 24, 2022

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

March 30, 2022

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 6, 2022

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 25, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 25, 2023

Completed
1.2 years until next milestone

Results Posted

Study results publicly available

November 8, 2024

Completed
Last Updated

November 8, 2024

Status Verified

October 1, 2023

Enrollment Period

1.4 years

First QC Date

March 30, 2022

Results QC Date

January 23, 2024

Last Update Submit

August 28, 2024

Conditions

Keywords

LaryngoscopyExercise-InducedLaryngeal ObstructionHeadgear

Outcome Measures

Primary Outcomes (1)

  • Percentage of Participants With Continuous Laryngoscopy During Exercise Tests

    The percentage of participants with continuous laryngoscopy during exercise tests where the endoscopy image was clear and stable enough to allow a diagnosis of exercise-induced laryngeal obstruction to be confirmed or ruled out.

    30 minutes

Secondary Outcomes (4)

  • Percentage of Participants With Device Usability Rating of 4 or 5

    60 minutes

  • Device Usability Subjective Feedback

    60 minutes

  • Percentage of Participants Scoring Device Tolerability as 3 or 4

    60 minutes

  • Device Tolerability Subjective Feedback

    60 minutes

Study Arms (1)

Participants

EXPERIMENTAL

Participants will be required to attend a single consultation and screening appointment to discuss the investigation procedure, and this will occur at least a week before the Continuous Laryngoscopy during Exercise (CLE) test. Participants will then attend one appointment for the CLE test. There will be no follow up assessments using the headgear.

Device: Continuous laryngoscopy during exercise test using the HALOS headgear

Interventions

The participant will undergo the CLE test following standard clinical practice. The order of events of the aspects of the investigation related to the headgear will be: 1. The headgear is prepared for use. 2. The headgear is fitted onto the participant's head. 3. The endoscope is inserted into the participant. 4. The endoscope is fitted onto the headgear. 5. The CLE test is carried out. 6. The endoscope is removed from the headgear. 7. The endoscope is removed from the participant. 8. The headgear is removed from the participant. 9. The headgear is cleaned and stored.

Participants

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Participant is willing and able to give informed consent for participation in the study.
  • Male, female or non-binary, aged 18 years or above.
  • Able (in the Investigators opinion) and willing to comply with all study requirements.
  • Able to undergo a CLE test as judged by the clinician, and where a clinical need of the test for the delivery of healthcare has been identified.

You may not qualify if:

  • Pain, sore areas, broken skin at the site of contact with the headgear.
  • Devices, e.g. cochlear implants, that impede the use of the headgear.
  • Head circumference is less than 50cm or greater than 63cm, reflecting the 3rd centile for females and 97th centile for males, respectively (Bushby, 1992).
  • Skull base/facial surgery or fracture within the previous six weeks
  • Major or life threatening epistaxis within the previous six weeks
  • Trauma to nasal cavity secondary to surgery or injury within the previous six weeks
  • Sino-nasal and anterior skull base tumours/surgery
  • Nasopharyngeal stenosis
  • Craniofacial anomalies
  • Hereditary haemorrhagic telangiectasia
  • Severe movement disorders and/or severe agitation
  • Vasovagal history
  • Bleeding risks

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Liverpool University Hospitals Nhs Foundation Trust

Liverpool, Merseyside, L7 8XP, United Kingdom

Location

Results Point of Contact

Title
Dr Tristan Payne
Organization
Liverpool University Hospitals NHS Foundation Trust

Study Officials

  • Tristan Payne

    Liverpool University Hospitals NHS Foundation Trust

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Model Details: The study is an interventional clinical trial involving a single group of 30 participants undergoing a continuous laryngoscopy during exercise test with the HALOS headgear.
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 30, 2022

First Posted

April 6, 2022

Study Start

March 24, 2022

Primary Completion

August 25, 2023

Study Completion

August 25, 2023

Last Updated

November 8, 2024

Results First Posted

November 8, 2024

Record last verified: 2023-10

Locations